Nova (NVMI) Cash & Equivalents (2009 - 2025)

Nova has reported Cash & Equivalents for 17 years, with the latest figure at $214.5 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 35.93% year-over-year to $214.5 million; the trailing twelve-month figure through Dec 2025 stood at $214.5 million (up 35.93% YoY), and the FY2025 full-year result was $214.5 million, up 35.93% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $214.5 million, down from $521.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $521.6 million in Q3 2025, with the low at $96.1 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $172.9 million across 5 years, with a median of $135.7 million in 2024.
• Annual changes were most pronounced in 2021 — Cash & Equivalents soared 631.71% — and 2022, when it tumbled 54.72%.
• Nova's Cash & Equivalents stood at $232.3 million in 2021, then sank by 52.17% to $111.1 million in 2022, then slipped by 3.19% to $107.6 million in 2023, then jumped by 46.67% to $157.8 million in 2024, then soared by 35.93% to $214.5 million in 2025.
• The last three Cash & Equivalents figures came in at $214.5 million (Q4 2025), $521.6 million (Q3 2025), and $160.6 million (Q2 2025), per Business Quant data.